Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Adrian Klimiuk

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 3, 2004
[Therapeutic efficacy of peloid plasters in the treatment of osteoarthritis of the peripheral joints and spondylosis]Piotr Adrian Klimiuk, Elzbieta Muklewicz, Stanisław Sierakowski
Polskie Archiwum Medycyny Wewnetrznej|July 26, 2003
[Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis]Piotr Adrian Klimiuk, Stanisław Sierakowski, Justyna Chwiećko
Clinical Rheumatology|September 7, 2004
Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvementAnna Kuryliszyn-Moskal, Piotr Adrian Klimiuk, Stanislaw Sierakowski
Clinical Rheumatology|November 13, 2009
Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patientsMariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Piotr Adrian Klimiuk
Rheumatology International|December 22, 2009
Serum chemokines in patients with rheumatoid arthritis treated with etanerceptPiotr Adrian Klimiuk, Stanislaw Sierakowski, Izabela Domyslawska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 20, 2006
[Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis]Małgorzata Fiedorczyk, Piotr Adrian Klimiuk, Stanisław Sierakowski, et al.
Clinical Rheumatology|July 30, 2008
The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritisPiotr Adrian Klimiuk, Jacek Kita, Justyna Chwiecko, et al.
The Journal of Rheumatology|February 5, 2004
Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritisPiotr Adrian Klimiuk, Stanislaw Sierakowski, Izabela Domyslawska, et al.
Rheumatology International|September 6, 2014
Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockersPiotr Adrian Klimiuk, Izabela Domysławska, Stanisław Sierakowski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 13, 2004
[Kidneys in rheumatoid arthritis]Bogdan Lewandowski, Piotr Adrian Klimiuk, Karol Kita, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|November 3, 2004
[Therapeutic efficacy of peloid plasters in the treatment of osteoarthritis of the peripheral joints and spondylosis]Piotr Adrian Klimiuk, Elzbieta Muklewicz, Stanisław Sierakowski
Polskie Archiwum Medycyny Wewnetrznej|July 26, 2003
[Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis]Piotr Adrian Klimiuk, Stanisław Sierakowski, Justyna Chwiećko
Clinical Rheumatology|September 7, 2004
Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvementAnna Kuryliszyn-Moskal, Piotr Adrian Klimiuk, Stanislaw Sierakowski
Clinical Rheumatology|November 13, 2009
Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patientsMariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Piotr Adrian Klimiuk
Rheumatology International|December 22, 2009
Serum chemokines in patients with rheumatoid arthritis treated with etanerceptPiotr Adrian Klimiuk, Stanislaw Sierakowski, Izabela Domyslawska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 20, 2006
[Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis]Małgorzata Fiedorczyk, Piotr Adrian Klimiuk, Stanisław Sierakowski, et al.
Clinical Rheumatology|July 30, 2008
The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritisPiotr Adrian Klimiuk, Jacek Kita, Justyna Chwiecko, et al.
The Journal of Rheumatology|February 5, 2004
Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritisPiotr Adrian Klimiuk, Stanislaw Sierakowski, Izabela Domyslawska, et al.
Rheumatology International|September 6, 2014
Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockersPiotr Adrian Klimiuk, Izabela Domysławska, Stanisław Sierakowski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 13, 2004
[Kidneys in rheumatoid arthritis]Bogdan Lewandowski, Piotr Adrian Klimiuk, Karol Kita, et al.
Pageof 4